• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

HIV exposure and infection affect neurodevelopmental outcomes in young children

byShyam AkulaandCordelia Ross
January 26, 2018
in Infectious Disease, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Children less than 8 years old infected with HIV and children who were HIV exposed-but-uninfected had poorer neurodevelopmental outcomes compared to unexposed children.

2. Those children who were either HIV-infected or exposed-but-uninfected who also had anti-retroviral exposure may have lower neuropsychological function than those without anti-retroviral exposure.

Evidence Rating Level: 2 (Good)

Study Rundown: HIV infection is known to result in worse neurodevelopmental outcomes in children born to HIV-infected mothers. However, less is known about the outcomes of children who are HIV exposed-but-uninfected (HEU), as well as the impact of anti-retroviral (ARV) exposure on neurodevelopment. In this study, authors conducted a systematic review and meta-analysis of literature pertaining to neurodevelopmental outcomes of children born to HIV-infected mothers. They reviewed 45 studies, 11 of which were used for meta-analysis. Neurodevelopmental outcomes were measured using a standardized neuropsychological assessment tool, the Bayley Scales of Infant and Toddler Development (BSID). HIV infected (HIV+) children and HEU children showed worse cognitive and motor outcomes compared with uninfected (HUU) children, and HEU children showed better outcomes compared to HIV+ children. Furthermore, ARV exposure may also be associated with poorer developmental outcomes, but further data in this area is necessary. Overall, this meta-analysis is a comprehensive, standardized comparison of neurodevelopmental outcomes in these 3 groups of children; however, results were limited by study heterogeneity, and confounders such as location were not controlled for. Overall, this study provides the first, quantitative analysis of neurodevelopment outcomes in HIV-exposed children. This study points to the necessity for more data regarding ARV exposure in the perinatal period. Findings also provide a baseline for efforts to improve neurodevelopmental outcomes in a vulnerable population.

Click to read the study, published today in Pediatrics 

Relevant Reading: Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers

In-Depth [systematic review and meta-analysis]: This meta-analysis reviewed 45 studies, 11 of which were included in a network meta-analysis that met the authors’ criteria. Studies were included based on the use of a standardized neuropsychological assessment (BSID), an age cutoff of 8 years old for subjects, and lack of significant confounding factors. HUU children were used as the statistical reference group. Systematic heterogeneity was assessed with subgroup analysis and meta-regression, and studies were analyzed for their quality, with sub-analyses based on quality ratings. Adjusted meta regression results of both measurements of the Mental Developmental Index (MDI), as well as the Psychomotor Developmental Index (PDI) from within the BSID showed HIV+ children having poorer outcomes than HUU children on both scales (MDI: -16.3 points, 95% CI: [-26.2, -7.1]; PDI: -17.62 points, 95% CI: [-27.3, -7.6]). HEU children showed lower outcomes to a lesser extent (MDI: -6.61 points, 95% CI: [-15.5, 2.54]; PDI: -4.25 points, 95% CI: [-13.71, 5.12]). Measuring the effect of ARV exposure on BSID scores for HIV+ and HEU children suggested a possible effect of ARVs: exposed children had lower mean scores than those unexposed to ARVs in both subdomains of the BSID examined, compared to HUU children (MDI: [HEU: -10.0 vs. 0.95, HIV+: -20.3 vs -7.8]); (PDI: [HEU: -5.5 vs. -1.2, HIV+: -19.4 vs -12.7]).

RELATED REPORTS

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

Liposomal amphotericin B noninferior to standard treatment for cryptococcal meningitis

High-dose Hepatitis B revaccination schedule improves serological response among patients with Human Immunodeficiency Virus

Image: CC

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antiretroviralHIV/AIDShuman immunodeficiency virus (HIV)
Previous Post

Shorter duration of glecaprevir-pibrentasvir effective against hepatitis C virus: The ENDURANCE trials

Next Post

The PARADIGM-HF trial: Valsartan-neprilysin inhibitor vs. enalapril in patients with heart failure [Classic Series]

RelatedReports

Gardasil vaccine demonstrates immunogenic response at 10-year follow-up
Chronic Disease

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

May 18, 2022
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Chronic Disease

Liposomal amphotericin B noninferior to standard treatment for cryptococcal meningitis

March 29, 2022
Compliance-linked incentives increase infant immunizations rates in rural India
Chronic Disease

High-dose Hepatitis B revaccination schedule improves serological response among patients with Human Immunodeficiency Virus

August 24, 2021
Government-funded initiatives provide important supports to low-income HIV patients
Chronic Disease

Targeted screening not superior to nontargeted screening for human immunodeficiency virus in the emergency department

July 29, 2021
Next Post
Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The PARADIGM-HF trial: Valsartan-neprilysin inhibitor vs. enalapril in patients with heart failure [Classic Series]

Greater rates of mortality linked to infants at risk for maltreatment

Free alternatives comparable to Mini-Mental State Examination

2 Minute Medicine Rewind January 29, 2018

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ciprofol comparable to propofol for general anesthesia induction for gynecological surgery
  • Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
  • Type of compensation model influences gender pay gap in primary care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.